Document Detail


Effects of sulfaphenazole derivatives on cardiac ischemia-reperfusion injury: association of cytochrome P450 activity and infarct size.
MedLine Citation:
PMID:  20644334     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiac ischemia-reperfusion injury is evoked by reactive oxygen species (ROS). We previously reported that sulfaphenazole (SPZ) attenuated cardiac ROS levels and ischemia-reperfusion injury in rats. SPZ has distinct two actions: a) elimination of ROS and b) inhibition of cytochrome P450 (CYP) that is responsible for ROS production. The aim of this study is to determine which action contributes to the attenuation of cardiac ischemia-reperfusion injury using SPZ and its derivatives [acetyl-SPZ (Ac-SPZ) and dichloro-SPZ (2Cl-SPZ)]. Administration of 2Cl-SPZ or SPZ prior to ischemia significantly reduced myocardial infarct size, myocardial lipid peroxides, and ROS levels. In addition, they inhibited rat cardiac CYP activity. However, Ac-SPZ neither reduced infarct size nor inhibited cardiac CYP activity. The three compounds had similar effects on ROS scavenging activity in that they scarcely scavenged hydrogen peroxide and superoxide anions but reduced hydroxyl radicals with the same efficacy. The serum concentration of each compound was almost the same until 24 h after reperfusion. Collectively, our findings indicate that the suppressive effects of SPZ and 2Cl-SPZ on ischemia-reperfusion injury are associated with the reduction of ROS levels, which is primarily due to a decrease in ROS production via inhibition of cardiac CYP, not via ROS scavenging activity.
Authors:
Yasuhiro Ishihara; Masaya Sekine; Ai Hamaguchi; Yusuke Kobayashi; Takashi Harayama; Mikio Nakazawa; Norio Shimamoto
Related Documents :
23590154 - Brief daily episode of normoxia inhibits cardioprotection conferred by chronic continuo...
23394554 - Ivabradine: the hope for a good treatment of ischemic heart disease.
17630344 - Expression of serca isoform with faster ca2+ transport properties improves postischemic...
15381964 - Endoxin-mediated myocardial ischemia reperfusion injury in rats in vitro.
12754294 - Upregulation of cardiac insulin-like growth factor-i receptor by ace inhibition after m...
20724904 - Coronary artery phenotypes in subjects with negative myocardial perfusion imaging and t...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-07-13
Journal Detail:
Title:  Journal of pharmacological sciences     Volume:  113     ISSN:  1347-8648     ISO Abbreviation:  J. Pharmacol. Sci.     Publication Date:  2010  
Date Detail:
Created Date:  2010-08-20     Completed Date:  2010-12-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101167001     Medline TA:  J Pharmacol Sci     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  335-42     Citation Subset:  IM    
Affiliation:
Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences at Kagawa, Tokushima Bunri University, Sanuki, Kagawa, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Chromatography, High Pressure Liquid
Cytochrome P-450 Enzyme System / metabolism*
Electron Spin Resonance Spectroscopy
Humans
Myocardial Infarction / pathology*
Myocardial Reperfusion Injury / enzymology,  metabolism,  prevention & control*
Rats
Reactive Oxygen Species / metabolism
Spectrophotometry, Ultraviolet
Sulfaphenazole / pharmacology*
Thiobarbituric Acid Reactive Substances / metabolism
Chemical
Reg. No./Substance:
0/Reactive Oxygen Species; 0/Thiobarbituric Acid Reactive Substances; 526-08-9/Sulfaphenazole; 9035-51-2/Cytochrome P-450 Enzyme System

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of low-dose simvastatin on the distribution of plasma cholesterol and oxidized low-density l...
Next Document:  14-3-3 protein protects against cardiac endoplasmic reticulum stress (ERS) and ERS-initiated apoptos...